Subscribe to our Blog
Blog Insights from the Bench
Bispecific Antibody Services in 2026: A Look at the Current Landscape
Choosing a bispecific format is one decision. Choosing who builds the molecule, and on what terms, is a different one. Here's a look at the ...
Bispecific Antibody Purification: Anti-CH1 vs. Protein A
For transient proof-of-concept work, anti-CH1 capture with optimized DNA ratios is faster and cheaper than Protein A, which pays off once ...
A Crank of the Invenra Discovery Engine Produces Therapeutic Quality Antibodies
The traditional antibody discovery paradigm relies on animal immunization (WT or transgenic). It is a proven process but one with lengthy ...
Stay in the loop Subscribe to the Invenra Newsletter
Get new resources, insights, and platform updates right in your inbox. Unsubscribe anytime.
Only a few emails per month. No spam.